Review
Version 1
This version is not peer-reviewed
P450 in Liver Pathology Diagnostic
Version 1
: Received: 8 October 2024 / Approved: 9 October 2024 / Online: 10 October 2024 (06:17:52 CEST)
How to cite: Chesca, A. A.; Sandle, T. T. P450 in Liver Pathology Diagnostic. Preprints 2024, 2024100670. https://doi.org/10.20944/preprints202410.0670.v1 Chesca, A. A.; Sandle, T. T. P450 in Liver Pathology Diagnostic. Preprints 2024, 2024100670. https://doi.org/10.20944/preprints202410.0670.v1
Abstract
A specific key point in liver cirrhosis is the decreased metabolic capacity for drugs. So medicines which are metabolized by oxidative biotransformation play a great role in liver pathology. Responsible for the drug metabolism that takes place in liver during illnes, are three cytochrome P450 (P450 or CYP) gene families in liver microsomes (CYP 1, CYP2 and CYP3). In attention of various studies, is cytochrome P450. Folowing the currently aim,we try to assess the effect of liver disease on multiple CYP enzymes by use of a validated cocktail composed of medicins. Liver diseases are associated with metabolic activity changes It is important to know and to tell a little bit about different directions in cirrhosis diagnostic, including laboratory tests or management ideas.
Keywords
liver; alterations; diagnostic; ethiology; investigations
Subject
Public Health and Healthcare, Public Health and Health Services
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
